← Leaderboards
Jay Erdman
Astellas Pharma Global Development, Inc.
$3,000,000
Attributed
$6,000,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$6,000,000 · 1
By mechanism
UG3$6,000,000 · 1
Top collaborators
- Gerard Joseph Marek1 shared
Others in their field
Other Emerging Leaders on “Agonist”
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
- Aaron Esser-Kahn · University Of Chicago$13,378,548
- Nikej Shah · Nirsum Laboratories, Inc.$12,506,430
- Xinhua Li · Nano Terra, Inc.$11,941,250
- James Dale Berry · Brigham And Women'S Hospital$9,298,517
- James N Campbell · Centrexion Therapeutics Corporation$8,662,635
Research focus
AgonistAlcoholsAmericanAmericasApplications GrantsAreaAwardBaclofenBaseBloodBrainBuprenorphineButyric AcidsCardiacClinical ResearchClinical TrialsCocaineCorpus Striatum StructureCravingDigit StructureDopamineDoseDouble-Blind MethodAdverse Event